Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study-Reference-Cited by-同舟云学术

Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study

Published:2020-09-11 Issue:5 Volume:62 Page:675-678
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Farolfi Andrea,Hirmas Nader,Gafita Andrei,Weber Manuel,Barbato Francesco,Wetter Axel,Mei Riccardo,Pianori Davide,Hadaschik Boris,Herrmann Ken,Castellucci Paolo,Fanti Stefano,Eiber Matthias,Fendler Wolfgang P.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference19 articles.

1. Cancer statistics, 2018

2. A retrospective study of the time to clinical endpoints for advanced prostate cancer

3. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

4. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial;Fendler;JAMA Oncol.,2019

5. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial;Calais;Lancet Oncol.,2019

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Value of PSMA-RADS Version 2.0 in the Assessment of Pulmonary Metastases in Patients With Prostate Cancer and the Improvement of Differential Diagnosis Efficiency by PSMA PET/CT Parameters;Clinical Nuclear Medicine;2024-08-28

2. Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer;Seminars in Nuclear Medicine;2024-06

3. PSMA PET for Detection of Recurrence;Seminars in Nuclear Medicine;2024-01

4. PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?;Journal of Clinical Medicine;2023-11-16

5. Prostate-specific Membrane Antigen Reporting and Data System Version 2.0;European Urology;2023-11